CARL
Carlsmed, Inc. NASDAQ Listed Apr 5, 2018$11.71
Mkt Cap $318.3M
52w Low $8.50
36.9% of range
52w High $17.19
50d MA $10.65
200d MA $12.12
P/E (TTM)
-4.8x
EV/EBITDA
—
P/B
1.7x
Debt/Equity
0.2x
ROE
-30.0%
P/FCF
-5.6x
RSI (14)
51.90
ATR (14)
$0.83
Beta
3.66
50d MA
$10.65
200d MA
$12.12
Avg Volume
183.1K
Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. Its product includes aprevo, a medical platform that makes surgical plans and devices tailored to the precise medical situation of every individual patient. It provides New Technology Add-On Payment (NTAP) reimbursement. The company was incorporated in 2018 and is based in Carlsbad, California.
CIK (SEC)
Phone
(760) 766-1923
1800 Aston Avenue · Carlsbad, CA 92008 · US
Data updated apr 24, 2026 11:52pm
· Source: financialmodelingprep.com